Genmab — Marts 2018
-
God morgen.

-
Tak Legolas. Har vagten i familiens butik i hele denne weekend. Jeg skal have gjort klar til åbningen hos de nye naboer Normal, Jysk, Tiger, Wagner, Intersport, m.fl i næste uge. I aften spiser vi dog sammen med søn, datter og barnebarn på Elmely kro. Ingen grund til at fyre en stor fest af på en ung mand som kun fylder 60 år.

-
Tusinde tak.

-
Stort tillykke Helge

-
This old Ofa study has results - Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia - https://clinicaltrials.gov/ct2/show/results/NCT01515176?sect=X0156&term=daratumumab+OR+ofatumumab+OR+tisotumab&lupd_s=03%2F15%2F2018&rank=2#outcome7
-
This suspended - Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma- Recruitment Status : Suspended (Accrual objective has been met. Study will re-open pending IRB approval of MCCC Addendum 6) https://clinicaltrials.gov/ct2/show/NCT03012880?term=daratumumab+OR+ofatumumab+OR+tisotumab&lupd_s=03%2F15%2F2018&rank=3
-
Også stort tillykke herfra med den runde dag!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind